3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk prediction

Marcus C Hovens; Kevin Lo; Michael Kerger; John Pedersen; Timothy Nottle; Natalie Kurganovs; Andrew Ryan; Justin S Peters; Daniel Moon; Anthony J Costello; Niall M Corcoran; Matthew KH Hong

Journal article

3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk prediction

Marcus C Hovens, Kevin Lo, Michael Kerger, John Pedersen, Timothy Nottle, Natalie Kurganovs, Andrew Ryan, Justin S Peters, Daniel Moon, Anthony J Costello, Niall M Corcoran, Matthew KH Hong

PATHOLOGY RESEARCH AND PRACTICE | ELSEVIER GMBH | Published : 2017

DOI: 10.1016/j.prp.2017.09.022

Abstract

Prostate cancer displays a wide spectrum of clinical behaviour from biological indolence to rapidly lethal disease, but we remain unable to accurately predict an individual tumor's future clinical course at an early curable stage. Beyond basic dimensions and volume calculations, tumor morphometry is an area that has received little attention, as it requires the analysis of the prostate gland and tumor foci in three-dimensions. Previous efforts to generate three-dimensional prostate models have required specialised graphics units and focused on the spatial distribution of tumors for optimisation of biopsy strategies rather than to generate novel morphometric variables such as tumor surface ar..

View full abstract

University of Melbourne Researchers

Anthony Costello Author Surgery - Royal Melbourne Hospital

Daniel Moon Author Surgery - Royal Melbourne Hospital

Justin Peters Author Medical Education

Niall Corcoran Author Surgery - Royal Melbourne Hospital

Related Projects (2)

Investigation of the source of new testosterone production in prostate tumours that become resistant to existing hormonal (testosterone lowering and blocking) therapies

Prostate cancer is critically dependent upon continued testosterone stimulation, even when the disease becomes resistant to existing hormona..

Determining the origin of lethal metastases in multifocal primary prostate cancer

New biomarkers are required to accurately predict lethal prostate cancer from benign, indolent disaese that doesn't require expensive treatm..

Grants

Awarded by NHMRC

Funding Acknowledgements

M.K.H.H. was supported by scholarships from the National Health and Medical Research Council, Australia, University of Melbourne (Melville Hughes Scholarship) and the Royal Australasian College of Surgeons (Foundation of Surgery Catherine Marie Enright Kelly and ANZ Journal of Surgery Research Scholarships). N.M.C. is the recipient of a David Bickart Clinician Research Fellowship from the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. M.K. was supported by the Carlo Vaccari Scholarship and APCR. This work was supported in part by NHMRC project grants 1024081 (N.M.C., J.S.P., A.J.C. and C.M.H.) and 1047581 (C.M.H., G.M., I.H., J.S.P., A.J.C., N.M.C.), as well as a federal grant from the Australian Department of Health and Aging to the Epworth Cancer Centre, Epworth Hospital (A.J.C., N.M.C., C.M.H.).